US Stock MarketDetailed Quotes

VYGR Voyager Therapeutics

Watchlist
  • 7.000
  • +0.170+2.49%
Close Nov 1 16:00 ET
  • 7.040
  • +0.040+0.57%
Post 19:24 ET
381.73MMarket Cap25.93P/E (TTM)

Voyager Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
509.48%29.58M
-87.03%19.52M
511.16%250.01M
5,910.39%90.06M
-88.77%4.61M
581.60%4.85M
22,769.30%150.48M
9.33%40.91M
-105.52%-1.55M
2,672.33%41.09M
Operating revenue
509.48%29.58M
-87.03%19.52M
511.16%250.01M
5,910.39%90.06M
-88.77%4.61M
581.60%4.85M
22,769.30%150.48M
9.33%40.91M
-105.52%-1.55M
2,672.33%41.09M
Cost of revenue
Gross profit
Operating expense
47.31%44.6M
29.36%35.7M
39.51%127.99M
56.42%36M
28.06%34.12M
50.80%30.28M
25.39%27.6M
-17.37%91.74M
2.87%23.01M
0.06%26.64M
Selling and administrative expenses
22.39%10.15M
-4.66%8.61M
15.63%35.82M
21.04%10.24M
13.01%8.26M
9.83%8.29M
17.87%9.03M
-16.82%30.98M
1.33%8.46M
-16.15%7.31M
-General and administrative expense
22.39%10.15M
-4.66%8.61M
15.63%35.82M
21.04%10.24M
13.01%8.26M
9.83%8.29M
17.87%9.03M
-16.82%30.98M
1.33%8.46M
-16.15%7.31M
Research and development costs
56.71%34.45M
45.91%27.09M
51.69%92.17M
77.01%25.76M
33.75%25.86M
75.50%21.99M
29.40%18.57M
-17.65%60.76M
3.79%14.55M
7.94%19.34M
Operating profit
40.91%-15.03M
-113.17%-16.18M
340.01%122.01M
320.10%54.06M
-304.31%-29.51M
-31.29%-25.43M
675.57%122.88M
30.94%-50.84M
-530.78%-24.56M
157.43%14.44M
Net non-operating interest income expense
49.30%4.89M
161.11%4.87M
554.07%11.72M
223.16%3.15M
529.17%3.43M
1,394.98%3.27M
5,912.90%1.86M
559.49%1.79M
251.79%976K
350.41%545K
Non-operating interest income
49.30%4.89M
161.11%4.87M
----
----
529.17%3.43M
1,394.98%3.27M
5,912.90%1.86M
----
----
350.41%545K
Total other finance cost
----
----
-554.07%-11.72M
----
----
----
----
-559.49%-1.79M
----
----
Other net income (expense)
566.67%20K
-99.89%3K
0
-95.08%3K
-5.62%2.65M
-103.54%-23K
2,454.46%2.64M
Other non- operating income (expenses)
566.67%20K
----
-99.89%3K
--0
----
-95.08%3K
----
-5.62%2.65M
-103.54%-23K
2,454.46%2.64M
Income before tax
54.32%-10.12M
-109.07%-11.32M
388.28%133.74M
342.34%57.22M
-247.97%-26.08M
-16.04%-22.15M
685.15%124.75M
34.84%-46.39M
-513.56%-23.61M
170.11%17.62M
Income tax
-59.32%24K
-98.01%14K
8,700.00%1.41M
5,037.50%822K
-177K
59K
704K
16K
16K
0
Net income
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
170.11%17.62M
Net income continuous Operations
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
170.11%17.62M
Minority interest income
Net income attributable to the parent company
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
170.11%17.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
170.11%17.62M
Basic earnings per share
64.71%-0.18
-106.56%-0.2
354.55%3.08
301.64%1.23
-228.26%-0.59
-2.00%-0.51
644.64%3.05
35.98%-1.21
-506.67%-0.61
168.66%0.46
Diluted earnings per share
64.71%-0.18
-106.80%-0.2
345.45%2.97
295.08%1.19
-231.11%-0.59
-2.00%-0.51
625.00%2.94
35.98%-1.21
-506.67%-0.61
167.16%0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 509.48%29.58M-87.03%19.52M511.16%250.01M5,910.39%90.06M-88.77%4.61M581.60%4.85M22,769.30%150.48M9.33%40.91M-105.52%-1.55M2,672.33%41.09M
Operating revenue 509.48%29.58M-87.03%19.52M511.16%250.01M5,910.39%90.06M-88.77%4.61M581.60%4.85M22,769.30%150.48M9.33%40.91M-105.52%-1.55M2,672.33%41.09M
Cost of revenue
Gross profit
Operating expense 47.31%44.6M29.36%35.7M39.51%127.99M56.42%36M28.06%34.12M50.80%30.28M25.39%27.6M-17.37%91.74M2.87%23.01M0.06%26.64M
Selling and administrative expenses 22.39%10.15M-4.66%8.61M15.63%35.82M21.04%10.24M13.01%8.26M9.83%8.29M17.87%9.03M-16.82%30.98M1.33%8.46M-16.15%7.31M
-General and administrative expense 22.39%10.15M-4.66%8.61M15.63%35.82M21.04%10.24M13.01%8.26M9.83%8.29M17.87%9.03M-16.82%30.98M1.33%8.46M-16.15%7.31M
Research and development costs 56.71%34.45M45.91%27.09M51.69%92.17M77.01%25.76M33.75%25.86M75.50%21.99M29.40%18.57M-17.65%60.76M3.79%14.55M7.94%19.34M
Operating profit 40.91%-15.03M-113.17%-16.18M340.01%122.01M320.10%54.06M-304.31%-29.51M-31.29%-25.43M675.57%122.88M30.94%-50.84M-530.78%-24.56M157.43%14.44M
Net non-operating interest income expense 49.30%4.89M161.11%4.87M554.07%11.72M223.16%3.15M529.17%3.43M1,394.98%3.27M5,912.90%1.86M559.49%1.79M251.79%976K350.41%545K
Non-operating interest income 49.30%4.89M161.11%4.87M--------529.17%3.43M1,394.98%3.27M5,912.90%1.86M--------350.41%545K
Total other finance cost ---------554.07%-11.72M-----------------559.49%-1.79M--------
Other net income (expense) 566.67%20K-99.89%3K0-95.08%3K-5.62%2.65M-103.54%-23K2,454.46%2.64M
Other non- operating income (expenses) 566.67%20K-----99.89%3K--0-----95.08%3K-----5.62%2.65M-103.54%-23K2,454.46%2.64M
Income before tax 54.32%-10.12M-109.07%-11.32M388.28%133.74M342.34%57.22M-247.97%-26.08M-16.04%-22.15M685.15%124.75M34.84%-46.39M-513.56%-23.61M170.11%17.62M
Income tax -59.32%24K-98.01%14K8,700.00%1.41M5,037.50%822K-177K59K704K16K16K0
Net income 54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M170.11%17.62M
Net income continuous Operations 54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M170.11%17.62M
Minority interest income
Net income attributable to the parent company 54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M170.11%17.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M170.11%17.62M
Basic earnings per share 64.71%-0.18-106.56%-0.2354.55%3.08301.64%1.23-228.26%-0.59-2.00%-0.51644.64%3.0535.98%-1.21-506.67%-0.61168.66%0.46
Diluted earnings per share 64.71%-0.18-106.80%-0.2345.45%2.97295.08%1.19-231.11%-0.59-2.00%-0.51625.00%2.9435.98%-1.21-506.67%-0.61167.16%0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data